Geron board catches Lawlis director
This article was originally published in Scrip
Oncology biopharma Geron has appointed Dr V Bryan Lawlis to its board of directors and a member of the board's compensation committee. Dr Lawlis has over 30 years' experience in the biotechnology industry. He is a founder, president, CEO and a director of Itero Biopharmaceuticals, and also serves on the boards of BioMarin Pharmaceutical and Sutro Biopharma. Previously in his career, he founded the CRO Covance, and served as president and CEO of Aradigm Corporation.